Could This Probiotic Make Ozempic Obsolete?
Nick Norwitz, MD, PhD — Could This Probiotic Make Ozempic Obsolete?
Channel: Nick Norwitz MD PhD · Our label: Physician-researcher educator · Source: youtube.com/watch?v=wJ72xlhdpoQ
What this video covers
Scientists have just discovered the first of its kind living drug and it can completely change how we think about weight loss. It’s not a chemical, not a capsule of powder, but living cells engineered to move into your gut, taste what you eat. » And release medicine at the exact moment your body needs it. Think of tiny little pharmacies living and working inside of you.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
Nick Noritz, probably one of the top health and science research substacks out there right now, rising in the ranks, MD, PhD, who decided to go into content creation instead of clinical research and medicine.
- GLP-1 is the hormone that GLP-1 receptor agonists that family of weight loss drugs like ompic and goi taps into.
- So basically, the bacteria is sensing carbs and then responding by producing GLP-1, the same GLP-1 our body produces precisely when it’s needed to lower blood sugar, curb appetite, and improve metabolic health.
- Well, roughly 50% of people who start a GLP-1 for weight loss come off the drug within a year for reasons related to expense or GI side effects.
However, the lower GLP-1 dose with the living drug might also mean far fewer side effects like nausea and gastrointestinal upset.
- So imagine a living drug that detects intestinal inflammation, inflammatory cytoines, and releases an anti-inflammatory peptide on demand for need.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.